发明名称 Transforming anergic cancer patients into allergic state - with 2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazole
摘要 <p>In an investigation of the transformation of anergic patients (with no delayed hypersensitive reaction to skin-sensitizing antigens) into an allergic state (in which the above reaction is present, an effective amt. of 2,3,5,6-tetrahydro-6-phenylimidazo [2,1-b] thiazole (I), or its acid-addn. salts is administered to the patient and, after another challenge with the antigen (pref. 2,4-dinitrochlorobenzene or tuberculin), the patient is again examined for the required transformation. There is a connection between the ability of cancer patients to react to certain antigens and their operability, and (I) has been found to transform a statistically significant no. of anergic patients into positively reacting states.</p>
申请公布号 FR2196173(A1) 申请公布日期 1974.03.15
申请号 FR19730030085 申请日期 1973.08.17
申请人 JANSSEN PHARMACEUTICA NV,BE 发明人
分类号 A61K31/425;(IPC1-7):61K27/00;07D99/10 主分类号 A61K31/425
代理机构 代理人
主权项
地址